Koninklijke Philips N.V.

LONDON – – October 06, 2026 -- The global automated hydroponic gardening systems market is set to more than double from USD 1,676.5 million in 2024 to USD 3,871.92 million by 2032, a CAGR of 11.03%, according to a new report from Credence Research Inc.

Nutrient dosing and sensor-driven controls anchor commercial demand

Aggregate-type systems hold the largest share of the market, favored for broad crop compatibility and stable root support in both residential and scalable commercial installations. Nutrients lead the input category as automated dosing becomes central to crop consistency and yield control, while vegetables remain the dominant crop segment, driven by year-round demand for leafy greens, tomatoes, cucumbers and peppers.

Sheridan, Wyoming – September 20, 2026 -- The global remote patient monitoring (RPM) market is set to grow from $34.5 billion in 2026 to $62.2 billion by 2031, a 12.5% compound annual growth rate, according to a new study by Wissen Research.

Reimbursement codes and readmission penalties push hospitals toward RPM at scale

Dedicated CMS billing codes are giving U.S. providers a recurring revenue incentive to deploy RPM, while health systems use the technology to avoid costly 30-day readmission penalties tied to chronic disease relapse. Cardiovascular disease held the largest application share in 2025, reflecting the clinical and financial burden of heart failure, atrial fibrillation and hypertension.

SHERIDAN, WYOMING -- July 22, 2026 -- Royal Philips has received FDA 510(k) clearance for its next-generation reusable SpO₂ clip sensor, a pulse oximetry device built around internal optical refinements that improve signal quality. In desaturation testing, the sensor posted an accuracy result nearly twice as tight as the level recommended by ISO and recognized by the FDA. It also held accuracy within half a percentage point between light and dark skin pigmentation groups tested. The clearance extends Philips' broader pulse oximetry portfolio and follows a validation program built specifically around performance across diverse patient populations.

SHERIDAN, WYOMING -- July 22, 2026 -- Royal Philips has launched Alturion, a new ultrasound system built for departments that run high patient volumes across varied exam types. The system pairs AI-powered workflow tools with imaging hardware designed to hold up across shift changes and multiple users. Alturion has received FDA 510(k) clearance and CE mark certification, making it available now in the U.S. and Europe. Philips positions the launch as an expansion of its ultrasound portfolio rather than a standalone product, built to share transducers and interface design with existing systems already in clinical use.